| Thrombolytic therapy versus primary angioplasty. Which offers the best outcome after myocardial infarction? | |
| | |
MedLine Citation:
|
PMID: 9385334 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The best technique for reestablishing blood flow after myocardial infarction has been the subject of heated debate for more than a decade. An the answer is still elusive. Which option is the safest? Which salvages the most heart tissue? Dr Faxon explains the pros and cons of both thrombolysis and angioplasty and discusses the "90 rule," which helps determine the optimal reperfusion strategy for each individual patient. |
| | |
Authors:
|
D P Faxon |
Related Documents
:
|
1829574 - Coronary recanalization rate after intravenous bolus of alteplase in acute myocardial i... 6578454 - Coronary care at hutt hospital 1980-1981. 11676944 - Comparison of primary coronary angioplasty versus thrombolysis in patients with st-segm... 19105114 - Mechanical embolectomy in acute ischaemic stroke--report of the first two cases. 23008134 - Ecg and echocardiographic findings in 10-15-year-old elite athletes. 15127984 - Common scenarios to clarify the interpretation of cardiac markers. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Review |
Journal Detail:
|
Title: Postgraduate medicine Volume: 102 ISSN: 0032-5481 ISO Abbreviation: Postgrad Med Publication Date: 1997 Nov |
Date Detail:
|
Created Date: 1997-12-18 Completed Date: 1997-12-18 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0401147 Medline TA: Postgrad Med Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 97-8, 103-4, 107-8 passim Citation Subset: AIM; IM |
Affiliation:
|
University of Southern California School of Medicine 90033, USA. dfaxon@hsc.usc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary* Clinical Trials as Topic Fibrinolytic Agents / therapeutic use Humans Myocardial Infarction / drug therapy*, mortality, therapy* Thrombolytic Therapy* / adverse effects, contraindications Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Management of acute myocardial infarction. Synopsis of ACC and AHA practice guidelines. American Col...
Next Document: Role of cardiac markers in evaluation of suspected myocardial infarction. Selecting the most clinica...